ITI: N-[3-(5-{2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl}imidazo[2,1-b][1,3]thiazol-6-yl)phenyl]-2-phenylacetamide
ITI is a Ligand Of Interest in 3LZB designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3LZB_ITI_B_1 | 78% | 31% | 0.141 | 0.985 | 0.99 | 1.86 | 3 | 10 | 4 | 0 | 100% | 1 |
| 3LZB_ITI_A_1 | 69% | 29% | 0.156 | 0.973 | 1.06 | 1.88 | 4 | 14 | 8 | 0 | 100% | 1 |
| 3LZB_ITI_C_1 | 68% | 34% | 0.147 | 0.961 | 1.02 | 1.69 | 2 | 8 | 8 | 0 | 100% | 1 |
| 3LZB_ITI_D_1 | 53% | 42% | 0.182 | 0.944 | 0.85 | 1.43 | 3 | 5 | 13 | 0 | 100% | 1 |
